J2 Capital Management
ABBV icon

J2 Capital Management’s AbbVie ABBV Stock Holding History

J2 Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.78M Sell
6,786
-438
-6% -$112K 1.12% 16
2026
Q2 		$1.82M Buy
+7,224
New +$1.55M 1.22% 12

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

J2 Capital Management's ABBV Position: Q3 2026 in Review

J2 Capital Management reduced its AbbVie (ABBV) stake by 6.1% in Q3 2026, selling an estimated $112K and leaving 6,786 shares worth $1.78M. The position accounts for 1.12% of the portfolio, ranked #16.

J2 Capital Management first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.82M in Q2 2026. 1,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • J2 Capital Management held 6,786 shares of AbbVie worth $1.78M as of Q3 2026.
  • J2 Capital Management sold 438 AbbVie shares in Q3 2026, an estimated $112K.
  • AbbVie made up 1.12% of J2 Capital Management's portfolio in Q3 2026, its #16 holding.
  • J2 Capital Management first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • J2 Capital Management's AbbVie position peaked at $1.82M in Q2 2026.
  • 1,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on J2 Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.